Condition

Prostate Carcinoma Metastatic in the Bone

ClinicalTrials.gov condition label

Clinical trials17
Recruiting0
Common interventions25
Lead sponsors shown11

Clinical trials

17 shown
Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate CancerNCT03709550 · 2021-04-15
WITHDRAWN
ESK981 and Nivolumab for the Treatment of Metastatic Castration Resistant Prostate CancerNCT04159896 · 2019-11-13
TERMINATED
sEphB4-HSA in Treating Patients With Metastatic Castration-Resistant Prostate CancerNCT04033432 · 2019-09-20
UNKNOWN
Enzalutamide With Venetoclax in Treating Patients With Metastatic Castration Resistant Prostate CancerNCT03751436 · 2019-08-02
COMPLETED
Abiraterone Acetate, Prednisone, and Apalutamide in Treating Patients With Hormone-Naive Metastatic Prostate CancerNCT03821792 · 2019-07-22
ACTIVE_NOT_RECRUITING
Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or ProstateNCT03582475 · 2019-01-11
ACTIVE_NOT_RECRUITING
Enzalutamide With or Without Radium Ra 223 Dichloride in Patients With Metastatic, Castration-Resistant Prostate CancerNCT03344211 · 2018-11-21
ACTIVE_NOT_RECRUITING
Fluciclovine F18 PET/CT Imaging in Assessing Hormone-Naive Men With Prostate Cancer That Has Spread to the BoneNCT03707184 · 2018-10-02
COMPLETED
Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair DeficiencyNCT03442556 · 2018-08-24
TERMINATED
Pembro and HER2Bi-Armed Activated T Cells in Treating Patients With Metastatic Castration Resistant Prostate CancerNCT03406858 · 2018-06-07
COMPLETED
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With DocetaxelNCT03419234 · 2018-04-26
ACTIVE_NOT_RECRUITING
Avelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced MalignanciesNCT03217747 · 2017-08-02
ACTIVE_NOT_RECRUITING
Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal CordNCT02713269 · 2016-08-29
ACTIVE_NOT_RECRUITING
Docetaxel and Carboplatin in Treating Patients With Metastatic, Castration Resistant Prostate Cancer Containing Inactivated Genes in the BRCA 1/2 PathwayNCT02598895 · 2016-01-26
COMPLETED
Enzalutamide With Ribociclib in Treating Patients With Metastatic Castrate-Resistant, Chemotherapy Naive Prostate Cancer That Retains Retinoblastoma ExpressionNCT02555189 · 2015-12-01
TERMINATED
Selinexor in Treating Patients With Abiraterone Acetate and/or Enzalutamide Refractory Metastatic Castration-Resistant Prostate CancerNCT02215161 · 2014-09-02
TERMINATED
Cabazitaxel With or Without Carboplatin in Treating Patients With Previously Treated Metastatic Castration-Resistant Prostate CancerNCT01505868 · 2012-07-11
COMPLETED

Common interventions

Laboratory Biomarker AnalysisOTHER6CarboplatinDRUG4EnzalutamideDRUG4Computed TomographyPROCEDURE3DocetaxelDRUG3Abiraterone AcetateDRUG2CabazitaxelDRUG2PembrolizumabBIOLOGICAL2PrednisoneDRUG2Androgen deprivation therapyDRUG1ApalutamideDRUG1AvelumabDRUG1BiopsyPROCEDURE1Biospecimen CollectionPROCEDURE1Bone ScanPROCEDURE1CisplatinDRUG1DecitabineDRUG1EchocardiographyPROCEDURE1EtoposideDRUG1Fluciclovine F18DRUG1HER2Bi-Armed Activated T CellsBIOLOGICAL1IvuxolimabBIOLOGICAL1Magnetic Resonance ImagingPROCEDURE1Multigated Acquisition ScanPROCEDURE1NivolumabBIOLOGICAL1

Trial status mix

ACTIVE_NOT_RECRUITING6
COMPLETED5
TERMINATED4
UNKNOWN1
WITHDRAWN1

Phase mix

PHASE215
PHASE16

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.